Carboxypeptidase-D (CPD) and
carboxypeptidase-M (CPM) release C-terminal
arginine (Arg) from
polypeptides, and both are present in the plasma membrane. Cell-surface CPD increases intracellular Arg, which is converted to
nitric oxide (NO). We have reported that
prolactin (PRL) regulated CPD
mRNA levels in MCF-7
breast cancer cells. This study examined PRL/17beta-
estradiol (E2) regulation of CPD/CPM expression, and the role of CPD in NO production for survival of MCF-7 cells. We showed that PRL or E2 up-regulated CPD
mRNA and
protein expression. PRL/E2 increased CPD
mRNA levels by 3- to 5-fold but had no effect on CPM. In Arg-free DMEM, exogenous L-Arg or substrate
furylacryloyl-Ala-Arg (
Fa-Ala-Arg) increased NO levels and cell survival, measured using
4,5-diaminofluorescein diacetate and the MTS assay, respectively. In the presence of
Fa-Ala-Arg, NO production was enhanced by PRL and/or E2 but inhibited by CPD/CPM-specific inhibitor, 2-mercaptomethyl-3-guanidinoethylthio-propanoic
acid (MGTA). MGTA also decreased MCF-7 cell survival. In Arg-free medium,
annexin-V staining showed that apoptotic MCF-7 cells (approximately 60%) were rescued by
Fa-Ala-Arg (25%) or
diethylamine/NO (10%). Finally, CPD or CPM gene expression was knocked down with small interfering (si) CPD or siCPM, respectively, with nontargeting siNT as controls. In Arg-free DMEM, the stimulatory effect of
Fa-Ala-Arg on NO production was inhibited by siCPD only, showing that CPD depletion inhibited
Fa-Ala-Arg cleavage. Furthermore, more than 60% of siCPD-transfectants were apoptotic, and L-Arg, not
Fa-Ala-Arg, significantly decreased apoptosis to 32% (P<or=0.05). Thus, CPD gene knockdown did not affect L-Arg uptake, which protected cells from apoptosis. In summary, PRL/E2-induced cell-surface CPD released Arg from extracellular substrates, increased intracellular NO, promoted survival and inhibited apoptosis of MCF-7 cells.